-
Je něco špatně v tomto záznamu ?
Natural Products to Counteract the Epidemic of Cardiovascular and Metabolic Disorders
B. Waltenberger, A. Mocan, K. Šmejkal, EH. Heiss, AG. Atanasov,
Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články, přehledy
NLK
Directory of Open Access Journals
od 1997
Free Medical Journals
od 1997
PubMed Central
od 2001
Europe PubMed Central
od 2001
ProQuest Central
od 1997-01-01
Open Access Digital Library
od 1997-01-01
Medline Complete (EBSCOhost)
od 2009-03-01
Health & Medicine (ProQuest)
od 1997-01-01
- MeSH
- biguanidy terapeutické užití MeSH
- biologické přípravky terapeutické užití MeSH
- kardiovaskulární nemoci farmakoterapie MeSH
- léčivé rostliny * MeSH
- lidé MeSH
- metabolické nemoci farmakoterapie MeSH
- objevování léků MeSH
- statiny terapeutické užití MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
Natural products have always been exploited to promote health and served as a valuable source for the discovery of new drugs. In this review, the great potential of natural compounds and medicinal plants for the treatment or prevention of cardiovascular and metabolic disorders, global health problems with rising prevalence, is addressed. Special emphasis is laid on natural products for which efficacy and safety have already been proven and which are in clinical trials, as well as on plants used in traditional medicine. Potential benefits from certain dietary habits and dietary constituents, as well as common molecular targets of natural products, are also briefly discussed. A glimpse at the history of statins and biguanides, two prominent representatives of natural products (or their derivatives) in the fight against metabolic disease, is also included. The present review aims to serve as an "opening" of this special issue of Molecules, presenting key historical developments, recent advances, and future perspectives outlining the potential of natural products for prevention or therapy of cardiovascular and metabolic disease.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17023893
- 003
- CZ-PrNML
- 005
- 20170720124159.0
- 007
- ta
- 008
- 170720s2016 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/molecules21060807 $2 doi
- 035 __
- $a (PubMed)27338339
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Waltenberger, Birgit $u Institute of Pharmacy/Pharmacognosy and Center for Molecular Biosciences Innsbruck (CMBI), University of Innsbruck, 6020 Innsbruck, Austria; birgit.waltenberger@uibk.ac.at.
- 245 10
- $a Natural Products to Counteract the Epidemic of Cardiovascular and Metabolic Disorders / $c B. Waltenberger, A. Mocan, K. Šmejkal, EH. Heiss, AG. Atanasov,
- 520 9_
- $a Natural products have always been exploited to promote health and served as a valuable source for the discovery of new drugs. In this review, the great potential of natural compounds and medicinal plants for the treatment or prevention of cardiovascular and metabolic disorders, global health problems with rising prevalence, is addressed. Special emphasis is laid on natural products for which efficacy and safety have already been proven and which are in clinical trials, as well as on plants used in traditional medicine. Potential benefits from certain dietary habits and dietary constituents, as well as common molecular targets of natural products, are also briefly discussed. A glimpse at the history of statins and biguanides, two prominent representatives of natural products (or their derivatives) in the fight against metabolic disease, is also included. The present review aims to serve as an "opening" of this special issue of Molecules, presenting key historical developments, recent advances, and future perspectives outlining the potential of natural products for prevention or therapy of cardiovascular and metabolic disease.
- 650 _2
- $a biguanidy $x terapeutické užití $7 D001645
- 650 _2
- $a biologické přípravky $x terapeutické užití $7 D001688
- 650 _2
- $a kardiovaskulární nemoci $x farmakoterapie $7 D002318
- 650 _2
- $a objevování léků $7 D055808
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a statiny $x terapeutické užití $7 D019161
- 650 _2
- $a metabolické nemoci $x farmakoterapie $7 D008659
- 650 12
- $a léčivé rostliny $7 D010946
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Mocan, Andrei $u Department of Pharmaceutical Botany, Iuliu Haţieganu University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania; mocan.andrei@umfcluj.ro.
- 700 1_
- $a Šmejkal, Karel $u Department of Natural Drugs, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences Brno, 612 42 Brno, Czech Republic; karel.mejkal@post.cz.
- 700 1_
- $a Heiss, Elke H $u Department of Pharmacognosy, University of Vienna, 1090 Vienna, Austria; elke.heiss@univie.ac.at.
- 700 1_
- $a Atanasov, Atanas G $u Department of Pharmacognosy, University of Vienna, 1090 Vienna, Austria; elke.heiss@univie.ac.at. Institute of Genetics and Animal Breeding of the Polish Academy of Sciences, 05-552 Jastrzebiec, Poland. $7 gn_A_00009691
- 773 0_
- $w MED00180394 $t Molecules (Basel, Switzerland) $x 1420-3049 $g Roč. 21, č. 6 (2016)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/27338339 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20170720 $b ABA008
- 991 __
- $a 20170720124652 $b ABA008
- 999 __
- $a ok $b bmc $g 1239574 $s 984806
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2016 $b 21 $c 6 $e 20160622 $i 1420-3049 $m Molecules $n Molecules $x MED00180394
- LZP __
- $a Pubmed-20170720